The Clorox Company
CLX
$138.78
$0.510.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.17B | 7.47B | 7.09B | 7.21B | 7.31B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.17B | 7.47B | 7.09B | 7.21B | 7.31B |
| Cost of Revenue | 3.98B | 4.14B | 4.03B | 4.16B | 4.23B |
| Gross Profit | 3.19B | 3.33B | 3.07B | 3.05B | 3.08B |
| SG&A Expenses | 1.84B | 1.86B | 1.81B | 1.98B | 1.99B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 187.00M | 192.00M | 213.00M | 31.00M | 42.00M |
| Total Operating Expenses | 6.13B | 6.33B | 6.18B | 6.30B | 6.39B |
| Operating Income | 1.04B | 1.14B | 912.00M | 906.00M | 916.00M |
| Income Before Tax | 647.00M | 546.00M | 398.00M | 360.00M | 157.00M |
| Income Tax Expenses | 179.00M | 176.00M | 106.00M | 108.00M | 64.00M |
| Earnings from Continuing Operations | 468.00 | 370.00 | 292.00 | 252.00 | 93.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -11.00M | -13.00M | -12.00M | -12.00M | -13.00M |
| Net Income | 457.00M | 357.00M | 280.00M | 240.00M | 80.00M |
| EBIT | 1.04B | 1.14B | 912.00M | 906.00M | 916.00M |
| EBITDA | 1.25B | 1.36B | 1.14B | 1.13B | 1.15B |
| EPS Basic | 3.69 | 2.88 | 2.25 | 1.94 | 0.64 |
| Normalized Basic EPS | 4.75 | 5.20 | 4.04 | 4.01 | 4.03 |
| EPS Diluted | 3.66 | 2.87 | 2.24 | 1.92 | 0.62 |
| Normalized Diluted EPS | 4.72 | 5.18 | 4.03 | 3.99 | 4.02 |
| Average Basic Shares Outstanding | 496.11M | 496.52M | 496.70M | 496.22M | 495.62M |
| Average Diluted Shares Outstanding | 498.64M | 498.60M | 498.57M | 498.16M | 497.56M |
| Dividend Per Share | 4.86 | 4.84 | 4.82 | 4.80 | 4.78 |
| Payout Ratio | 131.07% | 167.23% | 212.50% | 246.67% | 737.50% |